Company Ticker News March 3, 2022CRISPR Therapeutics - Progress Adds More Value Than Patent Setback Subtracts 0 0 Share
Company Ticker News February 16, 2022CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Tops Revenue Estimates 0 0 Share
Company Ticker News February 8, 2022CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know 0 0 Share
Press Release February 2, 2022CRISPR Therapeutics and ViaCyte, Inc. Announce First Patient Dosed in Phase 1 Clinical Trial of Novel Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes (T1D) 0 0 Share
Company Ticker News February 2, 2022Crispr Therapeutics begins dosing patients in Phase 1 trial for experimental type 1 diabetes treatment 0 0 Share
Company Ticker News January 29, 2022CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know 0 0 Share
